Acadia Pharmaceuticals Inc (ACAD)

Retained Earnings

-$1.78B

Quarterly · Period ending: · USD

ACAD logo

ACAD Retained Earnings

Latest reported-$1.78B
ACAD Quarterly Retained Earnings (-$68.37M → -$1.78B)
High-resolution chart · PNG

ACAD retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-1,778,249,000
-1,809,749,000
-1,813,386,000
-2,086,954,000
-2,158,733,000
-2,185,399,000
-2,204,386,000
-2,348,128,000
-2,380,893,000
-2,414,282,000
-2,430,837,000
-2,476,634,000
-2,411,458,000
-2,412,572,000
-2,369,551,000
-2,327,826,000
-2,300,643,000
-2,266,632,000
-2,153,576,000
-2,110,482,000
-2,096,025,000
-2,052,154,000
-1,985,706,000
-1,918,946,000
-1,834,286,000
-1,792,145,000
-1,704,122,000
-1,651,086,000
-1,609,108,000
-1,554,167,000
-1,468,863,000
-1,403,371,000
-1,341,233,000
-1,277,967,000
-1,223,671,000
-1,154,801,000
-1,089,553,000
-1,022,112,000
-933,979,000
-855,283,000
-783,670,000
-712,348,000
-662,586,000
-616,802,000
-577,896,000
-538,518,000
-498,143,000
-469,777,000
-444,991,000
-423,496,000
-405,668,000
-393,619,000
-382,924,000
-373,843,000
-367,720,000
-360,910,000
-358,508,000
-353,089,000
-346,871,000
-341,571,000
-336,495,000
-329,939,000
-324,106,000
-353,247,000
-349,020,000
-344,732,000
-339,245,000
-330,556,000
-321,828,000
-309,101,000
-294,100,000
-280,137,000
-264,523,000
-246,236,000
-229,856,000
-212,818,000
-196,773,000
-186,020,000
-173,466,000
-161,016,000
-149,753,000
-137,885,000
-128,418,100
-118,215,200
-105,909,100
-99,872,200
-94,283,000
-86,948,200
-80,733,600
-74,847,100
-68,365,900
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.